Use this button to switch between dark and light mode.

Experience a New Era in Legal Research with Free Access to Lexis+

In re Nat'l Prescription Opiate Litig.

In re Nat'l Prescription Opiate Litig.

Judicial Panel On Multidistrict Litigation

December 5, 2017, Filed

MDL No. 2804

Opinion

 [*1376]  TRANSFER ORDER

Before the Panel:1 Plaintiffs in 46 actions move under 28 U.S.C. § 1407 to centralize pretrial proceedings in the Southern District of Ohio or the Southern District of Illinois, but plaintiffs do not  [*1377]  oppose centralization in the Southern District of West Virginia. These cases concern the alleged improper marketing of and inappropriate distribution of various prescription opiate medications into cities, states and towns across the country. Plaintiffs' motion includes the 64 actions listed on Schedule A,2 which are pending in nine districts. Since plaintiffs filed this motion, the parties have notified the Panel of 115 potentially related actions.3

Responding plaintiffs' positions on centralization vary considerably. Plaintiffs in over 40 actions or potential tag-along actions support centralization. Plaintiffs in fifteen actions or potential tag-along actions oppose centralization altogether or oppose transfer of their action. In addition to opposing transfer, the State of West Virginia suggests that we delay transferring its case until the Southern District of West Virginia court [**2]  decides its motion to remand to state court. Third party payor plaintiffs in an Eastern District of Pennsylvania potential tag-along action (Philadelphia Teachers Health and Welfare Fund) oppose centralization of third party payor actions. Western District of Washington plaintiff City of Everett opposes centralization and, alternatively, requests exclusion of its case. Northern District of Illinois tag-along plaintiff City of Chicago asks the Panel to defer transfer of its action until document discovery is completed.

Defendants' positions on centralization also vary considerably. The "Big Three" distributor defendants,4 which reportedly distribute over 80% of the drugs at issue and are defendants in most cases, support centralization in the Southern District of West Virginia. These defendants request that the Panel either delay issuing its transfer order or delay transfer of their cases until their motions to dismiss are decided. Defendant distributor Miami-Luken also supports centralization in the Southern District of West Virginia. Multiple manufacturer defendants5 support centralization in the Southern District of New York or the Northern District of Illinois; defendant Malinckrodt, [**3]  LLC, takes no position on centralization but supports the same districts. Teva defendants6 suggest centralization in the Eastern District of Pennsylvania or the manufacturers' preferred districts. Physician defendants7 in three Ohio actions, who are alleged to be  [*1378]  "key opinion leaders" paid by manufacturing defendants, do not oppose centralization in the Southern District of Ohio.

Defendants in several Southern District of West Virginia cases oppose centralization. These defendants include several smaller distributor defendants or "closed" distributors that supply only their own stores.8 Many of these defendants specifically request exclusion of the claims against them from the MDL. Also, manufacturer Pfizer, Inc., opposes centralization and requests that we exclude any claims against it from this MDL.9

Read The Full CaseNot a Lexis Advance subscriber? Try it out for free.

Full case includes Shepard's, Headnotes, Legal Analytics from Lex Machina, and more.

290 F. Supp. 3d 1375 *; 2017 U.S. Dist. LEXIS 200501 **; 2017 WL 6031547

IN RE: NATIONAL PRESCRIPTION OPIATE LITIGATION

Subsequent History: Later proceeding at Bd. of Comm'rs of Allen v. Purdue Pharma LP, 2018 U.S. Dist. LEXIS 7299 (N.D. Ind., Jan. 17, 2018)

Transferred by In re Nat'l Prescription Opiate Litig., 2018 U.S. Dist. LEXIS 18544 (J.P.M.L., Feb. 1, 2018)

Transferred by In re Nat'l Prescription Opiate Litig., 2018 U.S. Dist. LEXIS 22139, 2018 WL 840067 (J.P.M.L., Feb. 12, 2018)

Transferred by In re Nat'l Prescription Opiate Litig., 2018 U.S. Dist. LEXIS 32553 (J.P.M.L., Feb. 26, 2018)

Transferred by In re Nat'l Prescription Opiate Litig., 2018 U.S. Dist. LEXIS 74905 (J.P.M.L., Feb. 28, 2018)

Related proceeding at Cty. of Dallas v. Purdue Pharma L.P., 2018 U.S. Dist. LEXIS 73931 (N.D. Tex., Mar. 7, 2018)

Transferred by In re Nat'l Prescription Opiate Litig., 2018 U.S. Dist. LEXIS 51117 (J.P.M.L., Mar. 22, 2018)

Transferred by In re Nat'l Prescription Opiate Litig., 2018 U.S. Dist. LEXIS 53325 (J.P.M.L., Mar. 29, 2018)

Transferred by In re Nat'l Prescription Opiate Litig., 2018 U.S. Dist. LEXIS 131985 (J.P.M.L., Apr. 5, 2018)

Transferred by In re Nat'l Prescription Opiate Litig., 2018 U.S. Dist. LEXIS 60499 (J.P.M.L., Apr. 10, 2018)

Transferred by In re Nat'l Prescription Opiate Litig., 2018 U.S. Dist. LEXIS 67494 (J.P.M.L., Apr. 23, 2018)

Related proceeding at Mayor of Baltimore v. Purdue Pharma L.P., 2018 U.S. Dist. LEXIS 70082, 2018 WL 1963816 (D. Md., Apr. 25, 2018)

Remanded by, Motion granted by, Motion denied by, As moot Anne Arundel Cty. v. Purdue, 2018 U.S. Dist. LEXIS 70083, 2018 WL 1963789 (D. Md., Apr. 25, 2018)

Related proceeding at In re Tex. Opioid Litig., 2018 Tex. LEXIS 400 (Tex., May 2, 2018)

Transferred by In re Nat'l Prescription Opiate Litig., 2018 U.S. Dist. LEXIS 78022, 2018 WL 2182288 (J.P.M.L., May 8, 2018)

Transferred by In re Nat'l Prescription Opiate Litig., 2018 U.S. Dist. LEXIS 88297 (J.P.M.L., May 25, 2018)

Transferred by In re Nat'l Prescription Opiate Litig., 2018 U.S. Dist. LEXIS 91019 (J.P.M.L., May 29, 2018)

Transferred by In re Nat'l Prescription Opiate Litig., 2018 U.S. Dist. LEXIS 91015 (J.P.M.L., May 30, 2018)

Transferred by In re Nat'l Prescription Opiate Litig., 2018 U.S. Dist. LEXIS 95280 (J.P.M.L., June 6, 2018)

Transferred by In re Nat'l Prescription Opiate Litig., 2018 U.S. Dist. LEXIS 96117 (J.P.M.L., June 6, 2018)

Remanded by, Stay denied by, As moot, Motion denied by, As moot, Motion granted by N.M. ex rel. Balderas v. Purdue Pharma L.P., 323 F. Supp. 3d 1242, 2018 U.S. Dist. LEXIS 99235, 2018 WL 2943246 (D.N.M., June 12, 2018)

Transferred by In re Nat'l Prescription Opiate, Litig., 2018 U.S. Dist. LEXIS 99138 (J.P.M.L., June 13, 2018)

Transferred by In re Nat'l Prescription Opiate Litig., 2018 U.S. Dist. LEXIS 118572 (J.P.M.L., July 16, 2018)

Related proceeding at County of Spartanburg v. Rite Aid of S.C., Inc., 2018 U.S. Dist. LEXIS 185367 (D.S.C., July 25, 2018)

Later proceeding at Polk Cty. v. Purdue Pharma L.P., 2018 U.S. Dist. LEXIS 125652 (M.D. Fla., July 27, 2018)

Transferred by In re Nat'l Prescription Opiate Litig., 2018 U.S. Dist. LEXIS 130043 (J.P.M.L., Aug. 1, 2018)

Transferred by In re Nat'l Prescription Opiate Litig., 2018 U.S. Dist. LEXIS 134631 (J.P.M.L., Aug. 9, 2018)

Transferred by In re Nat'l Prescription Opiate Litig., 2018 U.S. Dist. LEXIS 136468, 2018 WL 3863456 (J.P.M.L., Aug. 13, 2018)

Transferred by In re Nat'l Prescription Opiate Litig., 2018 U.S. Dist. LEXIS 142758 (J.P.M.L., Aug. 22, 2018)

Remanded by Montana v. Purdue Pharma (In re Nat'l Prescription Opiate Litig.), 2018 U.S. Dist. LEXIS 143589, 2018 WL 4019413 (N.D. Ohio, Aug. 23, 2018)

Later proceeding at Montgomery Cty. Bd. of County Comm'rs v. Cardinal Health, Inc., 2018 U.S. Dist. LEXIS 169403, 2018 WL 4369976 (S.D. Ohio, Sept. 11, 2018)

Later proceeding at In re Nat'l Prescription Opiate Litig., 2018 U.S. Dist. LEXIS 158166 (J.P.M.L., Sept. 17, 2018)

Transferred by In re Nat'l Prescription Opiate Litig., 2018 U.S. Dist. LEXIS 163236 (J.P.M.L., Sept. 24, 2018)

Transferred by In re Nat'l Prescription Opiate Litig., 2018 U.S. Dist. LEXIS 170489 (J.P.M.L., Oct. 3, 2018)

Transferred by In re Nat'l Prescription Opiate Litig., 2018 U.S. Dist. LEXIS 172422 (J.P.M.L., Oct. 4, 2018)

Transferred by In re Nat'l Prescription Opiate Litig., 2018 U.S. Dist. LEXIS 180862 (J.P.M.L., Oct. 22, 2018)

Later proceeding at Bd. of Cty. Comm'rs v. Purdue Pharma L.P., 2018 U.S. Dist. LEXIS 183640, 2018 WL 5307623 (N.D. Okla., Oct. 26, 2018)

Transferred by In re Nat'l Prescription Opiate Litig., 2018 U.S. Dist. LEXIS 195905 (J.P.M.L., Nov. 14, 2018)

Later proceeding at Bd. of Cty. Comm'rs v. Purdue Pharma, L.P., 2018 U.S. Dist. LEXIS 194017, 2018 WL 5973752 (N.D. Okla., Nov. 14, 2018)

Later proceeding at Bd. of Cty. Comm'rs v. Purdue, 2018 U.S. Dist. LEXIS 194019, 2018 WL 5973761 (N.D. Okla., Nov. 14, 2018)

Later proceeding at City of Portland v. Pardue Pharma, LP, 2018 U.S. Dist. LEXIS 201070, 2018 WL 6191127 (D. Me., Nov. 28, 2018)

Transfer denied by In re Infants Born Opioid-Dependent Prods. Liab. Litig., 350 F. Supp. 3d 1377, 2018 U.S. Dist. LEXIS 206577, 2018 WL 6427191 (J.P.M.L., Dec. 6, 2018)

Transferred by, Motion denied by In re Nat'l Prescription Opiate Litig., 2018 U.S. Dist. LEXIS 208460 (J.P.M.L., Dec. 10, 2018)

Related proceeding at Tubhope v. AmerisourceBergen Drug Corp., 2018 U.S. Dist. LEXIS 210720 (W.D. Mo., Dec. 14, 2018)

Transferred by In re Nat'l Prescription Opiate Litig., 2018 U.S. Dist. LEXIS 216809 (J.P.M.L., Dec. 20, 2018)

Transferred by In re Nat'l Prescription Opiate Litig., 2018 U.S. Dist. LEXIS 216808 (J.P.M.L., Dec. 27, 2018)

Transferred by In re Nat'l Prescription Opiate Litig., 2019 U.S. Dist. LEXIS 9304 (J.P.M.L., Jan. 18, 2019)

Transferred by In re Nat'l Prescription Opiate Litig., 2019 U.S. Dist. LEXIS 22090 (J.P.M.L., Feb. 11, 2019)

Transferred by In re Nat'l Prescription Opiate Litig., 2019 U.S. Dist. LEXIS 37757 (J.P.M.L., Mar. 8, 2019)

Motion granted by In re Nat'l Presciption Opiate Litig., 2019 U.S. Dist. LEXIS 65557, 2019 WL 1529955 (N.D. Ohio, Apr. 5, 2019)

Later proceeding at In re Nat'l Prescription Opiate Litig., 2019 U.S. Dist. LEXIS 62546 (J.P.M.L., Apr. 11, 2019)

Later proceeding at In re Nat'l Prescription Opiate Litig., 2019 U.S. Dist. LEXIS 70985, 2019 WL 1872908 (N.D. Ohio, Apr. 26, 2019)

Transferred by In re Nat'l Prescription Opiate Litig., 2019 U.S. Dist. LEXIS 82519 (J.P.M.L., May 15, 2019)

Related proceeding at Roanoke Cty. v. Purdue, 2019 U.S. Dist. LEXIS 104003, 2019 WL 8333528 (W.D. Va., May 16, 2019)

Transferred by In re Nat'l Prescription Opiate Litig., 2019 U.S. Dist. LEXIS 89915 (J.P.M.L., May 24, 2019)

Related proceeding at, Stay granted by Louisa Cnty. v. Purdue Pharma, LP, 2019 U.S. Dist. LEXIS 204296 (W.D. Va., May 24, 2019)

Transferred by, in part In re Nat'l Prescription Opiate Litig., 2019 U.S. Dist. LEXIS 108699 (J.P.M.L., June 28, 2019)

Objection overruled by Lee Cty. v. Purdue Pharma, LP (In re Nat'l Prescription, Opiate Litig.), 2019 U.S. Dist. LEXIS 113661 (N.D. Ohio, July 9, 2019)

Transferred by In re Nat'l Prescription Opiate Litig., 2019 U.S. Dist. LEXIS 114230 (J.P.M.L., July 9, 2019)

Related proceeding at, Stay denied by Mecklenburg Cty. v. Purdue Pharma, L.P., 2019 U.S. Dist. LEXIS 118361, 2019 WL 3207795 (E.D. Va., July 12, 2019)

Transferred by In re Nat'l Prescription Opiate Litig., 2019 U.S. Dist. LEXIS 129695 (J.P.M.L., Aug. 2, 2019)

Transferred by In re Nat'l Prescription Opiate Litig., 2019 U.S. Dist. LEXIS 132022 (J.P.M.L., Aug. 2, 2019)

Motion granted by, Motion denied by, Without prejudice Cty. of Summit v. Purdue Pharma L.P. (In re Nat'l Prescription Opiate Litig.), 2019 U.S. Dist. LEXIS 130561, 2019 WL 3553892 (N.D. Ohio, Aug. 5, 2019)

Motion granted by, Motion denied by, As moot In re Nat'l Prescription Opiate Litig., 2019 U.S. Dist. LEXIS 138292 (N.D. Ohio, Aug. 14, 2019)

Motion granted by, Motion denied by, As moot In re Nat'l Prescription Opiate Litig., 2019 U.S. Dist. LEXIS 138296, 2019 WL 3843082 (N.D. Ohio, Aug. 15, 2019)

Partial summary judgment denied by, Partial summary judgment granted by In re Nat'l Prescription Opiate Litig., 2019 U.S. Dist. LEXIS 140020, 2019 WL 3917575 (N.D. Ohio, Aug. 19, 2019)

Related proceeding at Rosen-Hoffberg Rehab. & Pain Mgmt. Assocs., P.A. v. Medical Mut. Liab. Ins. Soc'y of Md., 2019 Md. App. LEXIS 711, 2019 WL 3936226 (Md. Ct. Spec. App., Aug. 20, 2019)

Transferred by In re Nat'l Prescription Opiate Litig., 2019 U.S. Dist. LEXIS 178506 (J.P.M.L., Aug. 22, 2019)

Motion denied by In re Nat'l Prescription Opiate Litig., 2019 U.S. Dist. LEXIS 144587, 2019 WL 4011855 (N.D. Ohio, Aug. 26, 2019)

Motion denied by In re Nat'l Prescription Opiate Litig., 2019 U.S. Dist. LEXIS 144579, 2019 WL 4043943 (N.D. Ohio, Aug. 26, 2019)

Motion denied by In re Nat'l Prescription Opiate Litig., 2019 U.S. Dist. LEXIS 144586, 2019 WL 4011729 (N.D. Ohio, Aug. 26, 2019)

Motion denied by, Motion denied by, As moot, in part In re Nat'l Prescription Opiate Litig., 2019 U.S. Dist. LEXIS 144585 (N.D. Ohio, Aug. 26, 2019)

Related proceeding at Takoma Reg'l Hosp., Inc. v. Purdue Pharma, L.P., 2019 U.S. Dist. LEXIS 226082, 2019 WL 7756112 (E.D. Tenn., Oct. 4, 2019)

Motion granted by, Dismissed by Hanlon v. Purdue Pharma, L.P. (In re Nat'l Prescription Opiate Litig.), 2019 U.S. App. LEXIS 34350 (6th Cir., Nov. 18, 2019)

Stay denied by In re Nat'l Prescription Opiate Litig., 2020 U.S. Dist. LEXIS 11216, 2020 WL 349277 (N.D. Ohio, Jan. 21, 2020)

Summary judgment denied by In re Nat'l Prescription Opiate Litig., 2020 U.S. Dist. LEXIS 13107 (N.D. Ohio, Jan. 27, 2020)

Related proceeding at, Dismissed by, Stay granted by City of Henderson v. Purdue, 2020 U.S. Dist. LEXIS 12871, 2020 WL 428112 (E.D. Ky., Jan. 27, 2020)

Motion granted by In re Nat'l Prescription Opiate Litig., 2020 U.S. Dist. LEXIS 22017, 2020 WL 582151 (J.P.M.L., Feb. 5, 2020)

Transferred by In re Nat'l Prescription Opiate Litig., 2020 U.S. Dist. LEXIS 22018 (J.P.M.L., Feb. 5, 2020)

Transferred by In re Nat'l Prescription Opiate Litig., 2020 U.S. Dist. LEXIS 22019 (J.P.M.L., Feb. 5, 2020)

Related proceeding at City of Huntington v. AmerisourceBergen Drug Corp., 2020 U.S. Dist. LEXIS 21513 (S.D. W. Va., Feb. 7, 2020)

Motion granted by In re Nat'l Prescription Opiate Litig., 2020 U.S. Dist. LEXIS 98730 (N.D. Ohio, Feb. 13, 2020)

Motion denied by, in part, Claim dismissed by Cleveland Bakers & Teamsters Health & Welfare Fund v. Purdue Pharma L.P. (In re Nat'l Prescription Opiate Litig.), 440 F. Supp. 3d 773, 2020 U.S. Dist. LEXIS 30360, 2020 WL 871539 (N.D. Ohio, Feb. 21, 2020)

Related proceeding at Bass v. Purdue Pharma, L.P., 2020 U.S. Dist. LEXIS 29685, 2020 WL 859307 (D.N.J., Feb. 21, 2020)

Transferred to In re Nat'l Prescription Opiate Litig., 2020 U.S. Dist. LEXIS 253109 (J.P.M.L., Mar. 30, 2020)

Motion granted by In re Nat'l Prescription Opiate Litig., 2020 U.S. Dist. LEXIS 56096, 2020 WL 1526726 (N.D. Ohio, Mar. 31, 2020)

Motion granted by, in part, Motion denied by, in part, Dismissed by, in part In re Nat'l Prescription Opiate Litig., 458 F. Supp. 3d 665, 2020 U.S. Dist. LEXIS 76515, 2020 WL 2090355 (N.D. Ohio, Apr. 30, 2020)

Transferred by In re Nat'l Prescription Opiate Litig., 2020 U.S. Dist. LEXIS 85130 (J.P.M.L., May 14, 2020)

Motion granted by, Stay granted by In re Nat'l Prescription Opiate Litig., 2020 U.S. Dist. LEXIS 96242, 2020 WL 2850288 (N.D. Ohio, June 2, 2020)

Motion denied by, As moot In re Nat'l Prescription Opiate Litig., 2020 U.S. Dist. LEXIS 257589, 2020 WL 8675733 (N.D. Ohio, June 3, 2020)

Objection overruled by, in part, Objection sustained by, in part In re Nat'l Prescription Opiate Litig., 2020 U.S. Dist. LEXIS 103781, 2020 WL 3166631 (N.D. Ohio, June 15, 2020)

Motion dismissed by In re Nat'l Prescription Opiate Litig., 2020 U.S. App. LEXIS 22245 (6th Cir., July 16, 2020)

Motion granted by In re Nat'l Prescription Opiate Litig., 2020 U.S. Dist. LEXIS 249094 (N.D. Ohio, July 24, 2020)

Transferred by In re Nat'l Prescription Opiate Litig., 2020 U.S. Dist. LEXIS 152260 (J.P.M.L., Aug. 21, 2020)

Related proceeding at Cincinnati Ins. Co. v. Disc. Drug Mart, Inc., 2020 Ohio Misc. LEXIS 964 (Ohio C.P., Sept. 8, 2020)

Transferred by In re Nat'l Prescription Opiate Litig., 2020 U.S. Dist. LEXIS 173739 (J.P.M.L., Sept. 21, 2020)

Motion denied by In re Nat'l Prescription Opiate Litig., 2020 U.S. Dist. LEXIS 173997, 2020 WL 5642173 (N.D. Ohio, Sept. 22, 2020)

Motion granted by, in part, Sanctions allowed by In re Nat'l Prescription Opiate Litig., 2020 U.S. Dist. LEXIS 190923, 2020 WL 6083455 (N.D. Ohio, Oct. 14, 2020)

Objection overruled by, in part, Objection sustained by, in part, Objection overruled by, in part, As moot In re Nat'l Prescription Opiate Litig., 2020 U.S. Dist. LEXIS 205381 (N.D. Ohio, Nov. 3, 2020)

Motion granted by, Motion denied by, Motion denied by, Without prejudice In re Nat'l Prescription Opiate Litig., 2020 U.S. Dist. LEXIS 204908, 2020 WL 6450290 (N.D. Ohio, Nov. 3, 2020)

Motion granted by In re Nat'l Prescription Opiate Litig., 2020 U.S. Dist. LEXIS 215600, 2020 WL 6785310 (N.D. Ohio, Nov. 18, 2020)

Related proceeding at, Stay granted by Paintsville Hosp. Co. v. Pharms., 2020 U.S. Dist. LEXIS 224414, 2020 WL 7048275 (E.D. Ky., Dec. 1, 2020)

Later proceeding at In re Nat'l Prescription Opiate Litig., 2020 U.S. Dist. LEXIS 235225, 2020 WL 7330956 (N.D. Ohio, Dec. 9, 2020)

Transferred by In re Nat'l Prescription Opiate Litig., 2020 U.S. Dist. LEXIS 236359 (J.P.M.L., Dec. 16, 2020)

Stay denied by, Reserved by, in part In re Nat'l Prescription Opiate Litig., 2021 U.S. App. LEXIS 2207, 2021 WL 3777638 (6th Cir., Jan. 12, 2021)

Class certification denied by Doyle v. Purdue Pharma L.P. (In re Nat'l Prescription Opiate Litig.), 2021 U.S. Dist. LEXIS 18475, 2021 WL 320754 (N.D. Ohio, Feb. 1, 2021)

Related proceeding at In re McKinsey & Co., 2021 U.S. Dist. LEXIS 108446 (J.P.M.L., June 7, 2021)

Stay denied by, Motion denied by, As moot Salih v. Plaintiff's Liaison Counsel (In re Nat'l Prescription Opiate Litig.), 2021 U.S. App. LEXIS 25122 (6th Cir., Aug. 20, 2021)

Summary judgment denied by In re Nat'l Prescription Opiate Litig., 2021 U.S. Dist. LEXIS 166043, 2021 WL 3917174 (N.D. Ohio, Sept. 1, 2021)

Motion granted by, in part, Motion denied by, in part In re Nat'l Prescription Opiate Litig., 2021 U.S. Dist. LEXIS 168499, 2021 WL 4060359 (N.D. Ohio, Sept. 7, 2021)

Motion granted by, in part, Motion denied by, in part In re Nat'l Prescription Opiate Litig., 2021 U.S. Dist. LEXIS 172640, 2021 WL 4146672 (N.D. Ohio, Sept. 13, 2021)

Motion denied by In re Nat'l Prescription Opiate Litig., 2021 U.S. Dist. LEXIS 172644, 2021 WL 4146245 (N.D. Ohio, Sept. 13, 2021)

Motion denied by In re Nat'l Prescription Opiate Litig., 2021 U.S. Dist. LEXIS 172701, 2021 WL 4146262 (N.D. Ohio, Sept. 13, 2021)

Motion denied by, Motion denied by, As moot In re Nat'l Prescription Opiate Litig., 2021 U.S. Dist. LEXIS 172702, 2021 WL 4146254 (N.D. Ohio, Sept. 13, 2021)

Motion denied by In re Nat'l Prescription Opiate Litig., 2021 U.S. Dist. LEXIS 205164, 2021 WL 4952468 (N.D. Ohio, Oct. 25, 2021)

Motion granted by In re Nat'l Prescription Opiate Litig., 2021 U.S. Dist. LEXIS 225317 (N.D. Ohio, Nov. 23, 2021)

Transferred by, Motion denied by In re Nat'l Prescription Opiate Litig., 2021 U.S. Dist. LEXIS 237233, 2021 WL 5872554 (J.P.M.L., Dec. 10, 2021)

Related proceeding at Cincinnati Ins. Co. v. Disc. Drug Mart, Inc., 2021-Ohio-4604, 2021 Ohio App. LEXIS 4553, 2021 WL 6142648 (Ohio Ct. App., Cuyahoga County, Dec. 30, 2021)

Transferred to In re Nat'l Prescription Opiate Litig., 2022 U.S. Dist. LEXIS 17861 (J.P.M.L., Feb. 1, 2022)

Later proceeding at In re Harris Cty., 2022 U.S. App. LEXIS 3394 (6th Cir., Feb. 7, 2022)

CORE TERMS

centralization, oppose, manufacturers, distributor, cases, opiates, prescription, districts, pretrial, parties, diversion, tag-along